“Uterus in a Dish” - Advancing Female Biology for Better Drug Discovery
Patient-derived uterine organoids for faster, more accurate R&D in endometriosis, fibroids, and beyond.
Opal Therapeutics is a women’s health biotech company developing lab-grown uterine models—including endometrial and myometrial organoids—to transform how we study and treat conditions like fibroids, endometriosis, and other gynecological disorders.
Our Mission: R&D services and therapeutic development for women’s health
We use patient-derived uterine organoids that mimic the structure and biology of real human tissue. Our models provide a more accurate, scalable, and clinically relevant platform for developing and testing treatments in women’s health.
Traditional rodent models don’t replicate key features of the female reproductive system, like menstrual cycling or uterine tissue dynamics, making them unreliable for developing effective treatments in women’s health.
Our labs
135 Mississippi Street
San Francisco, CA 94107